nifedipine has been researched along with Arteriosclerosis in 86 studies
Nifedipine: A potent vasodilator agent with calcium antagonistic action. It is a useful anti-anginal agent that also lowers blood pressure.
Arteriosclerosis: Thickening and loss of elasticity of the walls of ARTERIES of all sizes. There are many forms classified by the types of lesions and arteries involved, such as ATHEROSCLEROSIS with fatty lesions in the ARTERIAL INTIMA of medium and large muscular arteries.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The International Nifedipine GITS study: Intervention as a Goal in Hypertension Treatment (INSIGHT) is the first, large, randomized, double-blind study undertaken exclusively in high-risk hypertensive patients, with CV events as a prospectively defined primary end-point." | 4.81 | Long-term protection in at-risk hypertensive patients--a role for nifedipine GITS? ( Ruilope, LM, 2002) |
| "We studied 34 older, nonsmoking patients (mean age 74 +/- 5 years) with uncomplicated hypertension before and after the normalization of blood pressure (BP) was achieved with the angiotensin-converting enzyme inhibitor quinapril alone or in combination with the Ca2+ antagonist nifedipine." | 3.70 | Platelet hyperactivity in hypertensive older patients is controlled by lowering blood pressure. ( Di Veroli, C; Gazzaniga, PP; Lenti, L; Marigliano, V; Pignatelli, P; Pulcinelli, FM; Riondino, S, 1999) |
| " The atherogenic significance of Ca ions and arterial Ca overload was examined under the influence of nicotine, oxidatively modified low-density lipoproteins, spontaneous hypertension, and an elevated extracellular Ca concentration or vitamin D3." | 3.69 | Experimental vasoprotection by calcium antagonists against calcium-mediated arteriosclerotic alterations. ( Czirfuzs, A; Fleckenstein-Grün, G; Frey, M; Matyas, S; Thimm, F, 1994) |
| "We compared the effect of two different calcium channel blockers (CCB), Nifedipine (1,4-dihydropyridine calcium antagonist) and Diltiazem (a benzothiazepine agent) on plasma components and the development of atherosclerotic plaque in experimental hypercholesterolemia." | 3.69 | Differential effect of two calcium channel blockers--nifedipine and diltiazem--on atherogenesis in hypercholesterolemic hamster. ( Pojoga, L; Raicu, M; Simionescu, M; Simionescu, N, 1996) |
| "The effect of nicardipine on experimental hyperlipemia induced by a 1% cholesterol diet in spontaneously hypertensive rats (SHR) was investigated by the change of hemodynamics and the determination of lipid contents of the serum, liver, heart and aorta." | 3.67 | [Effect of nicardipine on cholesterol-fed S.H.R]. ( Kawashima, I; Nakayama, S; Ohba, T; Sakamoto, K; Tonooka, M; Yasuhara, H, 1985) |
| "Nifedipine was administered to 47 patients for 2 years, and the change of PWV was compared with age-matched control hemodialysis patients." | 2.67 | Effect of nifedipine administration on pulse wave velocity (PWV) of chronic hemodialysis patients--2-year trial. ( Hattori, Y; Okazawa, M; Saito, Y; Shirai, K; Uchino, J; Yoshida, S; Yoshida, T, 1990) |
| "Hypertension and hypercholesterolemia are frequently associated, and their treatment is proven to reduce cardiovascular risk." | 2.42 | Combined antihypertensive and lipid-lowering treatment. ( Cesari, M; Pessina, AC, 2004) |
| " Current data suggest that only early stages of coronary atheromatosis may be affected by treatment with calcium antagonists; however, optimum drug, dosage and suitable patients are yet to be defined." | 2.38 | Can the coronary atherosclerotic process be influenced by calcium antagonists? ( Cieslinski, G; Kaltenbach, M; Kober, G; Schneider, W, 1992) |
| " The higher the dosage used, the higher the regression of the atherosclerotic lesions." | 1.32 | Planimetric and histological study of the aortae in atherosclerotic chickens treated with nifedipine, verapamil and diltiazem. ( Ayala, I; Ballesta, J; Castells, MT; Fernández Pardo, J; García Pérez, B; Madrid, JF; Ortega, JV; Ortega, MR; Valdés, M, 2003) |
| "Nifedipine group (N) were fed 1% cholesterol chow and nifedipine 40 mg/animal/day." | 1.29 | [An experimental study on the mechanism of antiatherosclerotic effect of nifedipine]. ( Xu, ZC, 1993) |
| "Concomitantly, cardiac hypertrophy was attenuated in the treated group compared with the placebo group (heart-to-body weight ratios of 4." | 1.28 | Vascular injury: mechanisms and manifestations. ( Nayler, WG, 1991) |
| "Amlodipine is a long-acting dihydropyridine calcium antagonist with vascular selectivity." | 1.28 | Vascular and myocardial effects of amlodipine: an overview. ( Gu, XH; Nayler, WG, 1991) |
| " The log dose-response relationship of S." | 1.28 | Quantitative analysis of antiatherosclerotic effect of nifedipine in cholesterol-fed rabbits. ( Emura, S; Higuchi, N; Kato, H; Ohmori, K; Ohta, Y; Oogushi, K; Sunaga, T; Takashima, T, 1990) |
| " It is concluded that an antihypertensive dosage of nifedipine administered to animals with atherosclerosis does not suppress subsequent atherogenesis." | 1.27 | Hypertension and atherosclerosis in cholesterol-fed rabbits. II. One-kidney, one clip Goldblatt hypertension treated with nifedipine. ( Overturf, M; Schaper, J; Sybers, H; Taegtmeyer, H, 1987) |
| "Nifedipine has been implicated as an inhibitor of dietary induced atherosclerosis in rabbits." | 1.27 | The beneficial influence of nifedipine on the regression of the cholesterol-induced atherosclerosis in rabbits. ( Niedmann, PD; Seidel, D; Thiery, J, 1987) |
| "Nifedipine was well tolerated, and evoked only transient, moderate reductions in arterial pressure." | 1.26 | Suppression of atherogenesis in cholesterol-fed rabbit treated with nifedipine. ( Bentley, KI; Henry, PD, 1981) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 38 (44.19) | 18.7374 |
| 1990's | 38 (44.19) | 18.2507 |
| 2000's | 10 (11.63) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Simon, A | 1 |
| Levenson, J | 1 |
| Samra, SS | 1 |
| Walwaikar, PP | 1 |
| Morye, VK | 1 |
| Gawde, AG | 1 |
| García Pérez, B | 1 |
| Ayala, I | 1 |
| Castells, MT | 1 |
| Madrid, JF | 1 |
| Ortega, MR | 1 |
| Ortega, JV | 1 |
| Ballesta, J | 1 |
| Fernández Pardo, J | 1 |
| Valdés, M | 1 |
| Cesari, M | 1 |
| Pessina, AC | 1 |
| Iwasaki, Y | 1 |
| Asai, M | 1 |
| Yoshida, M | 1 |
| Nigawara, T | 1 |
| Kambayashi, M | 1 |
| Oiso, Y | 1 |
| Nakashima, N | 1 |
| Yoshida, D | 1 |
| Higashiura, K | 1 |
| Shimamoto, K | 1 |
| Yamagishi, S | 1 |
| Takeuchi, M | 1 |
| Komuro, I | 1 |
| Stone, KS | 1 |
| Scordo, KA | 1 |
| Beinart, C | 1 |
| Sos, TA | 1 |
| Saddekni, S | 1 |
| Weiner, MA | 1 |
| Sniderman, KW | 1 |
| Rouleau, JL | 1 |
| Parmley, WW | 2 |
| Stevens, J | 1 |
| Wikman-Coffelt, J | 1 |
| Sievers, R | 2 |
| Mahley, RW | 1 |
| Havel, RJ | 1 |
| Bertrand, ME | 1 |
| Lablanche, JM | 1 |
| Tilmant, PY | 1 |
| Thieuleux, FA | 1 |
| Naito, M | 1 |
| Kuzuya, F | 1 |
| Asai, K | 1 |
| Shibata, K | 1 |
| Yoshimine, N | 1 |
| Van Niekerk, JL | 1 |
| Hendriks, T | 1 |
| De Boer, HH | 1 |
| Van 't Laar, A | 1 |
| Williams, DO | 1 |
| Lorentsen, E | 1 |
| Landmark, K | 1 |
| Henry, PD | 2 |
| Bentley, KI | 1 |
| Pauletto, P | 1 |
| Da Ros, S | 1 |
| Zoleo, M | 1 |
| Rafflenbeul, W | 3 |
| Mizushige, K | 1 |
| DeMaria, AN | 1 |
| Matsuo, H | 1 |
| Fleckenstein-Grün, G | 2 |
| Thimm, F | 1 |
| Czirfuzs, A | 1 |
| Matyas, S | 1 |
| Frey, M | 2 |
| Takahashi, T | 1 |
| Tanaka, N | 1 |
| Tomochika, Y | 1 |
| Wasaki, Y | 1 |
| Tone, T | 1 |
| Shimizu, H | 1 |
| Matsuzaki, H | 1 |
| Matsuzaki, M | 1 |
| Porta, R | 1 |
| Conz, A | 1 |
| Conto, A | 1 |
| Pescador, R | 1 |
| Mantovani, M | 1 |
| Ferro, L | 1 |
| Xu, ZC | 1 |
| Akopov, SE | 3 |
| Gabrielian, ES | 3 |
| Alexander, JJ | 1 |
| Miguel, R | 1 |
| Piotrowski, JJ | 1 |
| Raicu, M | 1 |
| Pojoga, L | 1 |
| Simionescu, N | 1 |
| Simionescu, M | 1 |
| Haller, H | 1 |
| Weber, KT | 1 |
| Feuerstein, GZ | 1 |
| Fisher, M | 1 |
| Nunnart, J | 1 |
| Ruffolo, RR | 1 |
| Pitt, B | 1 |
| Kanayasu-Toyoda, T | 1 |
| Morita, I | 1 |
| Murota, S | 1 |
| Sasaki, R | 1 |
| Hirota, K | 1 |
| Masuda, A | 1 |
| Riondino, S | 1 |
| Pignatelli, P | 1 |
| Pulcinelli, FM | 1 |
| Lenti, L | 1 |
| Di Veroli, C | 1 |
| Marigliano, V | 1 |
| Gazzaniga, PP | 1 |
| Porcellini, M | 1 |
| Elia, S | 1 |
| Camera, L | 1 |
| Bracale, G | 1 |
| Inouye, M | 1 |
| Mio, T | 1 |
| Sumino, K | 1 |
| Ruilope, LM | 1 |
| Pola, P | 1 |
| Savi, L | 2 |
| Kober, G | 1 |
| Schneider, W | 1 |
| Cieslinski, G | 1 |
| Kaltenbach, M | 1 |
| Edelsteinová, S | 2 |
| Bohov, P | 1 |
| Lazarová, Z | 2 |
| Inczinger, F | 1 |
| Nayler, WG | 6 |
| Qin, S | 1 |
| Lojda, Z | 1 |
| Holub, P | 1 |
| Mrázková, O | 1 |
| Orekhov, AN | 2 |
| Tertov, VV | 1 |
| Lyakishev, AA | 1 |
| Gu, XH | 2 |
| Zhang, Y | 1 |
| Ghazarian, AV | 1 |
| Ohta, Y | 1 |
| Higuchi, N | 1 |
| Emura, S | 1 |
| Takashima, T | 1 |
| Oogushi, K | 1 |
| Kato, H | 1 |
| Ohmori, K | 1 |
| Sunaga, T | 1 |
| Knorr, AM | 1 |
| Kazda, S | 1 |
| Liu, JJ | 1 |
| Panagiotopoulos, S | 1 |
| Saito, Y | 1 |
| Shirai, K | 1 |
| Uchino, J | 1 |
| Okazawa, M | 1 |
| Hattori, Y | 1 |
| Yoshida, T | 1 |
| Yoshida, S | 1 |
| Orimo, H | 2 |
| Ouchi, Y | 1 |
| Atkinson, JB | 1 |
| Swift, LL | 1 |
| Weiss, K | 1 |
| Fitscha, P | 1 |
| Gazsó, A | 1 |
| Gludovacz, D | 1 |
| Sinzinger, H | 1 |
| Fleckenstein, A | 2 |
| Zorn, J | 1 |
| Koibuchi, Y | 1 |
| Sakai, S | 1 |
| Miura, S | 1 |
| Ono, T | 1 |
| Shibayama, F | 1 |
| Ohtsuka, M | 1 |
| Jackson, CL | 1 |
| Bush, RC | 1 |
| Bowyer, DE | 1 |
| Seuter, F | 1 |
| Lichtor, T | 1 |
| Davis, HR | 1 |
| Vesselinovitch, D | 1 |
| Wissler, RW | 1 |
| Mullan, S | 1 |
| Jennings, WC | 1 |
| Corder, CN | 1 |
| Jarolim, DR | 1 |
| Blackwell, J | 1 |
| Cherian, J | 1 |
| Chen, D | 1 |
| Handley, DA | 1 |
| Van Valen, RG | 1 |
| Melden, MK | 1 |
| Saunders, RN | 1 |
| Nilsson, J | 1 |
| Sjölund, M | 1 |
| Palmberg, L | 1 |
| Von Euler, AM | 1 |
| Jonzon, B | 1 |
| Thyberg, J | 1 |
| Lichtlen, PR | 1 |
| Nellessen, U | 1 |
| Jost, S | 1 |
| Hecker, H | 1 |
| Mori, S | 1 |
| Ito, H | 1 |
| Yamamoto, K | 1 |
| Mutoh, S | 2 |
| Nomoto, A | 2 |
| Sekiguchi, C | 2 |
| Yamaguchi, I | 2 |
| Overturf, M | 1 |
| Sybers, H | 1 |
| Schaper, J | 1 |
| Taegtmeyer, H | 1 |
| Thiery, J | 1 |
| Niedmann, PD | 1 |
| Seidel, D | 1 |
| Larach, DR | 1 |
| Zelis, R | 1 |
| Overturf, ML | 1 |
| Smith, SA | 1 |
| Hugenholtz, PG | 1 |
| Lichtlen, P | 1 |
| van der Giessen, W | 1 |
| Becker, AE | 1 |
| Hülsmann, WC | 1 |
| Ahn, YS | 1 |
| Jy, W | 1 |
| Harrington, WJ | 1 |
| Shanbaky, N | 1 |
| Fernandez, LF | 1 |
| Haynes, DH | 1 |
| Ishikawa, Y | 2 |
| Watanabe, N | 2 |
| Okamoto, R | 2 |
| Watanabe, Y | 2 |
| Fukuzaki, H | 2 |
| Hirosumi, J | 1 |
| Aoki, H | 1 |
| Fuchs, U | 1 |
| Fuchs, M | 1 |
| Hartwiger, P | 1 |
| Schuster, H | 1 |
| Terashita, K | 1 |
| Nakamura, T | 1 |
| Ohshima, J | 1 |
| Blumlein, S | 1 |
| Etingin, OR | 1 |
| Hajjar, DP | 1 |
| Cardillo, C | 1 |
| Guerrera, G | 1 |
| Melina, D | 1 |
| Ohba, T | 1 |
| Tonooka, M | 1 |
| Kawashima, I | 1 |
| Nakayama, S | 1 |
| Yasuhara, H | 1 |
| Sakamoto, K | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A European Multicentre Double-blind Placebo-controlled Phase III Trial of Nilvadipine in Mild to Moderate Alzheimer's Disease[NCT02017340] | Phase 3 | 511 participants (Actual) | Interventional | 2013-04-24 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
21 reviews available for nifedipine and Arteriosclerosis
| Article | Year |
|---|---|
Effects of calcium channel blockers on atherosclerosis: new insights.
Topics: Arteriosclerosis; Calcium Channel Blockers; Diuretics; Humans; Hydrochlorothiazide; Nifedipine; Sodi | 2002 |
Combined antihypertensive and lipid-lowering treatment.
Topics: Anticholesteremic Agents; Antihypertensive Agents; Arteriosclerosis; Cardiovascular Diseases; Comorb | 2004 |
[Treatment of hypertensive patients with impaired glucose tolerance (IGT)].
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive | 2005 |
Atheroprotective properties of nifedipine.
Topics: Animals; Antioxidants; Apoptosis; Arteriosclerosis; Calcium Channel Blockers; Cells, Cultured; Endot | 2005 |
[Can nifedipine prevent aging of blood vessels?].
Topics: Animals; Arteriosclerosis; Blood Vessels; Cellular Senescence; Muscle, Smooth, Vascular; Nifedipine | 2006 |
Understanding the calcium channel blockers.
Topics: Action Potentials; Angina Pectoris; Animals; Arrhythmias, Cardiac; Arteriosclerosis; Calcium; Calciu | 1984 |
Effects of antianginal agents on the coronary circulation.
Topics: Angina Pectoris; Animals; Arteriosclerosis; Calcium; Collateral Circulation; Coronary Circulation; C | 1981 |
Impact of nifedipine on vascular smooth muscle cell differentiation. Implications for atherogenesis.
Topics: Animals; Aorta; Arteriosclerosis; Cell Differentiation; Humans; Hypercholesterolemia; Immunohistoche | 1994 |
Hypertension treatment and prevention of new atherosclerotic plaque formation.
Topics: Animals; Arteriosclerosis; Calcium Channel Blockers; Coronary Angiography; Coronary Vessels; Endothe | 1994 |
Endothelial function. General considerations.
Topics: Animals; Arteriosclerosis; Calcium Channel Blockers; Capillary Permeability; Diabetes Mellitus; Endo | 1997 |
Pulvis de sclerotium and the mummified finger.
Topics: Algorithms; Arteriosclerosis; Calcium Channel Blockers; Ergotism; Humans; Nifedipine; Raynaud Diseas | 1997 |
Diversity of calcium antagonists.
Topics: Angina Pectoris; Arteriosclerosis; Benzimidazoles; Calcium Channel Blockers; Diltiazem; Humans; Hype | 1997 |
Anti-atherosclerotic properties of nifedipine. Benefit of early intervention to prevent cardiovascular complications.
Topics: Acute Disease; Animals; Arteriosclerosis; Calcium; Calcium Channel Blockers; Coronary Angiography; C | 1997 |
Intramural hematoma of the thoracic aorta in octogenarians: is non operation justified?
Topics: Aged; Aged, 80 and over; Analgesics; Aorta, Thoracic; Aortic Diseases; Aortography; Arteriosclerosis | 1999 |
Long-term protection in at-risk hypertensive patients--a role for nifedipine GITS?
Topics: Amiloride; Arteriosclerosis; Calcium Channel Blockers; Cardiovascular Diseases; Diuretics; Drug Comb | 2002 |
Can the coronary atherosclerotic process be influenced by calcium antagonists?
Topics: Animals; Arteriosclerosis; Cells, Cultured; Heart; Humans; Nifedipine; Prospective Studies; Retrospe | 1992 |
Influence of nifedipine on experimental arteriosclerosis.
Topics: Animals; Arteriosclerosis; Hypertension; Nifedipine; Rabbits; Rats | 1990 |
Advances in calcium blocker therapy.
Topics: Arrhythmias, Cardiac; Arteriosclerosis; Asthma; Blood Platelet Disorders; Calcium; Calcium Channel B | 1986 |
On a possible role for calcium antagonists in atherosclerosis. A personal view.
Topics: Animals; Arteriosclerosis; Calcium; Calcium Channel Blockers; Clinical Trials as Topic; Coronary Dis | 1986 |
Modification of experimental atherosclerosis by calcium-channel blockers.
Topics: Animals; Aorta; Arteriosclerosis; Calcium; Calcium Channel Blockers; Child; Diet, Atherogenic; Dilti | 1985 |
Atherosclerosis, calcium, and calcium antagonists.
Topics: Animals; Aorta; Arteries; Arteriosclerosis; Calcinosis; Calcium; Calcium Channel Blockers; Cell Surv | 1985 |
5 trials available for nifedipine and Arteriosclerosis
| Article | Year |
|---|---|
The relationship between the degradation of prostacyclin in blood and antiplatelet drug effects in patients with atherosclerosis.
Topics: Arteriosclerosis; Dipyridamole; Double-Blind Method; Epoprostenol; Humans; Kinetics; Middle Aged; Ni | 1993 |
Effects of aspirin, dipyridamole, nifedipine and cavinton which act on platelet aggregation induced by different aggregating agents alone and in combination.
Topics: Adenosine Diphosphate; Arteriosclerosis; Aspirin; Collagen; Dipyridamole; Double-Blind Method; Epine | 1992 |
Effect of nifedipine administration on pulse wave velocity (PWV) of chronic hemodialysis patients--2-year trial.
Topics: Adult; Arteriosclerosis; Heart; Humans; Hypertension; Middle Aged; Nifedipine; Pulse; Renal Dialysis | 1990 |
International nifedipine trial on antiatherosclerotic therapy (INTACT).
Topics: Adult; Arteriosclerosis; Double-Blind Method; Humans; Middle Aged; Nifedipine | 1987 |
On a possible role for calcium antagonists in atherosclerosis. A personal view.
Topics: Animals; Arteriosclerosis; Calcium; Calcium Channel Blockers; Clinical Trials as Topic; Coronary Dis | 1986 |
61 other studies available for nifedipine and Arteriosclerosis
| Article | Year |
|---|---|
Accelerated atherosclerosis.
Topics: Arteriosclerosis; Calcium Channel Blockers; Coronary Artery Bypass; Coronary Disease; Endothelium, V | 2002 |
Planimetric and histological study of the aortae in atherosclerotic chickens treated with nifedipine, verapamil and diltiazem.
Topics: Animals; Aorta, Abdominal; Aorta, Thoracic; Arteriosclerosis; Calcium Channel Blockers; Chickens; Ch | 2003 |
Nilvadipine inhibits nuclear factor-kappaB-dependent transcription in hepatic cells.
Topics: Arteriosclerosis; Base Sequence; Electrophoresis; Fibrinogen; Gene Expression; Hepatocytes; Humans; | 2004 |
Arterial spasm during renal angioplasty.
Topics: Adolescent; Adult; Aged; Angioplasty, Balloon; Arterial Occlusive Diseases; Arteriosclerosis; Child; | 1983 |
Verapamil suppresses atherosclerosis in cholesterol-fed rabbits.
Topics: Adenosine Triphosphatases; Administration, Oral; Animals; Aorta; Arteriosclerosis; Cholesterol, Diet | 1983 |
[Strategy of the treatment of vasospastic angina pectoris].
Topics: Adult; Amiodarone; Angina Pectoris, Variant; Arteriosclerosis; Coronary Artery Bypass; Coronary Vaso | 1983 |
Ineffectiveness of Ca2+-antagonists nicardipine and diltiazem on experimental atherosclerosis in cholesterol-fed rabbits.
Topics: Animals; Aorta; Arteriosclerosis; Benzazepines; Calcium; Cholesterol; Cholesterol, Dietary; Choleste | 1984 |
Does nifedipine suppress atherogenesis in WHHL rabbits?
Topics: Animals; Aorta; Arteriosclerosis; Cholesterol; Lipoproteins; Nifedipine; Rabbits; Triglycerides | 1984 |
The acute effects of nifedipine on calf and forefoot blood flow in patients with peripheral arterial insufficiency.
Topics: Arterial Occlusive Diseases; Arteriosclerosis; Blood Pressure; Foot; Humans; Leg; Nifedipine; Pyridi | 1983 |
Suppression of atherogenesis in cholesterol-fed rabbit treated with nifedipine.
Topics: Animals; Arteriosclerosis; Blood Pressure; Blood Proteins; Calcium; Cholesterol; Cholesterol, Dietar | 1981 |
[Evaluation of coronary arterial morphology using intravascular ultrasound].
Topics: Aged; Arteriosclerosis; Coronary Vessels; Elasticity; Humans; Nifedipine; Ultrasonography, Intervent | 1994 |
Experimental vasoprotection by calcium antagonists against calcium-mediated arteriosclerotic alterations.
Topics: Adult; Aged; Aged, 80 and over; Animals; Arteriosclerosis; Calcium; Calcium Channel Blockers; Cells, | 1994 |
Effects of nifedipine on mechanical properties of the normal and atherosclerotic descending aorta assessed by transesophageal echocardiography.
Topics: Adult; Aged; Aorta, Thoracic; Arteriosclerosis; Echocardiography, Transesophageal; Female; Humans; M | 1994 |
Comparable beneficial effects of defibrotide and nifedipine in calcium induced atherosclerosis.
Topics: Animals; Arteriosclerosis; Body Weight; Calcium; Calcium Channel Blockers; Male; Nifedipine; Polydeo | 1994 |
[An experimental study on the mechanism of antiatherosclerotic effect of nifedipine].
Topics: Animals; Aorta; Arteriosclerosis; Calcium; Cholesterol, Dietary; Cytoplasm; Male; Malondialdehyde; M | 1993 |
The effect of nifedipine on lipid and monocyte infiltration of the subendothelial space.
Topics: Animals; Arteriosclerosis; Calcium; Cattle; Cell Membrane Permeability; Cells, Cultured; Endothelium | 1993 |
Differential effect of two calcium channel blockers--nifedipine and diltiazem--on atherogenesis in hypercholesterolemic hamster.
Topics: Animals; Aorta, Thoracic; Aortic Valve; Arteriosclerosis; Calcium Channel Blockers; Coronary Vessels | 1996 |
Carvedilol inhibits aortic lipid deposition in the hypercholesterolemic rat.
Topics: Adrenergic beta-Antagonists; Animals; Aorta, Thoracic; Arteriosclerosis; Calcium Channel Blockers; C | 1997 |
Arachidonic acid pretreatment enhances smooth muscle cell migration via increased Ca2+ influx.
Topics: Animals; Arachidonic Acid; Arteriosclerosis; Becaplermin; Calcium; Calcium Channel Blockers; Cattle; | 1998 |
Nifedipine-induced transient cerebral ischemia in a child with Cockayne syndrome.
Topics: Arteriosclerosis; Brain Ischemia; Calcium Channel Blockers; Child; Cockayne Syndrome; Female; Humans | 1997 |
Platelet hyperactivity in hypertensive older patients is controlled by lowering blood pressure.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Arteriosclerosis; Blood Pre | 1999 |
Nilvadipine protects low-density lipoprotein cholesterol from in vivo oxidation in hypertensive patients with risk factors for atherosclerosis.
Topics: Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Arteriosclerosis; Case-Control Studies; Cho | 2000 |
Peripheral vascular dynamics studied by calcium ion inhibition.
Topics: Adult; Aged; Arteriosclerosis; Calcium; Diabetic Angiopathies; Humans; Middle Aged; Muscle, Smooth; | 1978 |
[Comparison of the effect of nifedipine and verapamil on lipid metabolism in experimental atherosclerosis in rabbits].
Topics: Animals; Arteriosclerosis; Fatty Acids; Lipids; Male; Nifedipine; Rabbits; Verapamil | 1992 |
Calcium, calcium antagonism, atherosclerosis, and ischemia.
Topics: Animals; Arteriosclerosis; Calcium; Coronary Disease; Cytosol; Humans; Hypercholesterolemia; Hyperte | 1992 |
[Inhibition of experimental atherosclerosis in swine by nifedipine].
Topics: Animals; Aorta; Arteriosclerosis; Male; Nifedipine; Swine; Swine, Miniature | 1992 |
[The effect of verapamil and nifedipine on the development of experimental atherosclerosis in rabbits].
Topics: Animals; Aorta; Arteriosclerosis; Lipids; Male; Nifedipine; Rabbits; Verapamil | 1992 |
Use of cultured atherosclerotic cells for investigation of antiatherosclerotic effects of anipamil and other calcium antagonists.
Topics: Aorta; Arteriosclerosis; Calcium Channel Blockers; Cell Division; Cells, Cultured; Cholesterol; Endo | 1991 |
Vascular injury: mechanisms and manifestations.
Topics: Amlodipine; Animals; Aorta, Thoracic; Arteriosclerosis; Calcium; Calcium Channel Blockers; Cardiomeg | 1991 |
Vascular and myocardial effects of amlodipine: an overview.
Topics: Amlodipine; Animals; Arteriosclerosis; Binding Sites; Calcium Channel Blockers; Cardiomegaly; Cerebr | 1991 |
[The effects of nifedipine, diltiazem, and Paeonia lactiflora Pall. on atherogenesis in rabbits].
Topics: Animals; Aorta; Arteriosclerosis; Diltiazem; Drugs, Chinese Herbal; Male; Nifedipine; Rabbits | 1991 |
Cerebral-artery spasm in vitro.
Topics: Arteriosclerosis; Cerebral Arteries; Dinoprost; Humans; In Vitro Techniques; Muscle Contraction; Nif | 1990 |
Quantitative analysis of antiatherosclerotic effect of nifedipine in cholesterol-fed rabbits.
Topics: Animals; Aorta; Arteriosclerosis; Body Weight; Cholesterol; Cholesterol, Dietary; Dose-Response Rela | 1990 |
Nifedipine and experimental cardioprotection.
Topics: Animals; Aorta, Thoracic; Arteriosclerosis; Binding Sites; Calcium; Cholesterol; Coronary Disease; E | 1990 |
Protecting the vasculature: an eye toward the future.
Topics: Amlodipine; Animals; Arteries; Arteriosclerosis; Blood Pressure; Calcium Channel Blockers; Cerebrova | 1990 |
The role of calcium and magnesium in the development of atherosclerosis. Experimental and clinical evidence.
Topics: Animals; Arteriosclerosis; Calcium; Cells, Cultured; DNA; Epidermal Growth Factor; Female; Guinea Pi | 1990 |
In vitro models of anti-atherosclerotic effects of cardiovascular drugs.
Topics: Arteriosclerosis; Cell Division; Cells, Cultured; Humans; Models, Biological; Muscle, Smooth, Vascul | 1990 |
Nifedipine reduces atherogenesis in cholesterol-fed heterozygous WHHL rabbits.
Topics: Animals; Aorta; Arteriosclerosis; Calcium; Cholesterol; Cholesterol Esters; Cholesterol, Dietary; Co | 1990 |
Calcium blockers: antiatherogenic action by influencing the prostaglandin-system.
Topics: Adult; Animals; Arteriosclerosis; Calcium Channel Blockers; Diltiazem; Epoprostenol; Female; Humans; | 1989 |
Amlodipine, a new 1,4-dihydropyridine calcium antagonist with a particularly strong antihypertensive profile.
Topics: Amlodipine; Animals; Antihypertensive Agents; Arteriosclerosis; Calcium; Calcium Channel Blockers; D | 1989 |
Suppression of atherogenesis in cholesterol-fed rabbits treated with nilvadipine, a new vasoselective calcium entry blocker.
Topics: Animals; Aorta, Thoracic; Arteriosclerosis; Blood Pressure; Calcium; Calcium Channel Blockers; Chole | 1989 |
Mechanism of antiatherogenic action of calcium antagonists.
Topics: Animals; Aorta, Abdominal; Aorta, Thoracic; Arteriosclerosis; Catheterization; DNA Replication; Male | 1989 |
[Pharmacologic inhibition of experimental atherosclerosis].
Topics: Animals; Arteriosclerosis; Cell Division; Disease Models, Animal; Dose-Response Relationship, Drug; | 1989 |
Suppression of atherogenesis by nifedipine in the cholesterol-fed rhesus monkey.
Topics: Animals; Arteries; Arteriosclerosis; Cholesterol, Dietary; Macaca mulatta; Male; Nifedipine | 1989 |
Atheromatous embolism: varied clinical presentation and prognosis.
Topics: Aged; Arteriosclerosis; Embolism; Female; Humans; Leg; Male; Middle Aged; Nifedipine; Prognosis; Sym | 1989 |
Suppression of rat carotid lesion development by the calcium channel blocker PN 200-110.
Topics: Angioplasty, Balloon; Animals; Arteriosclerosis; Blood Platelets; Blood Pressure; Carotid Arteries; | 1986 |
The calcium antagonist nifedipine inhibits arterial smooth muscle cell proliferation.
Topics: Actins; Animals; Arteries; Arteriosclerosis; Cell Division; Cyclic AMP; DNA; In Vitro Techniques; Ma | 1985 |
Effects of calcium antagonists on low density lipoprotein metabolism in human arterial smooth muscle cells.
Topics: Arteriosclerosis; Calcium Channel Blockers; Cells, Cultured; Humans; Lipoproteins, LDL; Muscle, Smoo | 1988 |
Protective action of a calcium antagonist, nilvadipine, against aortic calcium deposition--a pathogenic factor in atherosclerosis.
Topics: Animals; Aorta, Thoracic; Arteriosclerosis; Calcium; Calcium Channel Blockers; Dose-Response Relatio | 1988 |
Hypertension and atherosclerosis in cholesterol-fed rabbits. II. One-kidney, one clip Goldblatt hypertension treated with nifedipine.
Topics: Animals; Aorta; Arteriosclerosis; Blood Pressure; Cholesterol; Diet; Hematocrit; Hypertension, Renov | 1987 |
The beneficial influence of nifedipine on the regression of the cholesterol-induced atherosclerosis in rabbits.
Topics: Animals; Aorta; Apolipoproteins B; Arteriosclerosis; Cholesterol; Female; Hypercholesterolemia; Nife | 1987 |
Failure of nifedipine to reduce atherogenesis in cholesterol-fed rabbits.
Topics: Animals; Aorta; Arteriosclerosis; Blood Pressure; Cholesterol; Cholesterol, Dietary; Male; Nifedipin | 1986 |
Increased platelet calcium in thrombosis and related disorders and its correction by nifedipine.
Topics: Arteriosclerosis; Blood Platelets; Calcium; Homeostasis; Humans; Nifedipine; Thrombosis; Vascular Di | 1987 |
Nifedipine-suppressed atherosclerosis in cholesterol-fed rabbits but not in Watanabe heritable hyperlipidemic rabbits.
Topics: Animals; Arteriosclerosis; Cholesterol, Dietary; Hyperlipidemias; Male; Nifedipine; Rabbits | 1987 |
Antiatherogenic activity of FR34235 (Nilvadipine), a new potent calcium antagonist. Effect on cuff-induced intimal thickening of rabbit carotid artery.
Topics: Animals; Arteriosclerosis; Calcium Channel Blockers; Carotid Arteries; Carotid Artery Diseases; Male | 1987 |
Nifedipine suppressed atherosclerosis in cholesterol-fed rabbits but not in Watanabe heritable hyperlipidemic rabbits.
Topics: Administration, Oral; Animals; Aorta; Arteriosclerosis; Cholesterol, Dietary; Female; Hyperlipidemia | 1987 |
[Is there a hyporeactivity of the vascular wall to atherogenic risk factors?].
Topics: Aged; Aged, 80 and over; Animals; Aorta, Abdominal; Aorta, Thoracic; Arteriosclerosis; Endothelium; | 1986 |
Ca and atherosclerosis.
Topics: Aged; Aging; Animals; Aorta; Arteries; Arteriosclerosis; Bone Diseases; Calcinosis; Calcium; Calcium | 1985 |
Nifedipine increases cholesteryl ester hydrolytic activity in lipid-laden rabbit arterial smooth muscle cells. A possible mechanism for its antiatherogenic effect.
Topics: Animals; Arteriosclerosis; beta-Galactosidase; Cattle; Cells, Cultured; Cholesterol; Cholesterol Est | 1985 |
[Effect of nifedipine on peripheral blood flow in patients with atherosclerotic arterial disease of the lower limbs. A controlled study].
Topics: Arteriosclerosis; Humans; Leg; Nifedipine; Regional Blood Flow | 1985 |
[Effect of nicardipine on cholesterol-fed S.H.R].
Topics: Animals; Aorta; Arteriosclerosis; Body Weight; Heart Rate; Hyperlipidemias; Hypertension; Lipids; Li | 1985 |